>6 years or 73.9 months of os in the apalutamide adt group vs 59.9 months in the placebo adt group
online poll https://poll.fm/10792400 view past issues
asco daily news is the official conference reporter of the american society of clinical oncology (asco), providing high-quality, unbiased research summaries and oncology news to asco members and oncology health care providers.
ADS